Havens Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Havens Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17,000	Closed	-$3.69M	–	57
2021 Q1	$3.69M	Buy	+17,000	New	+$3.2M	3.26%	13

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Havens Advisors's GWPH Position: Q2 2021 in Review

Havens Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 17,000 shares — an estimated $3.69M sold.

Havens Advisors first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $3.69M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Havens Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Havens Advisors sold 17,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $3.69M.
Havens Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Havens Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.69M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Havens Advisors's 13F filing for Q2 2021, filed 14 Jul 2021.